>
Ono Pharmaceutical Co logo

4528 - Ono Pharmaceutical Co Share Price

¬•2485.5 -43.0  -1.7%

Last Trade - 30/07/21

Sector
Healthcare
Size
Large Cap
Market Cap £8.12bn
Enterprise Value £7.53bn
Revenue £2.02bn
Position in Universe 112th / 3912
Bullish
Bearish
Unlock 4528 Revenue
Momentum
Relative Strength (%)
1m +5.80%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -27.4%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Mar 2016 2017 2018 2019 2020 2021 2022E 2023E CAGR / Avg
160,284 244,797 261,836 288,634 292,420 309,284 348,531 394,938 +14.0%
+91.8 +135.7 -16.1 +10.1 +15.8 +27.6 +11.0 +21.6
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the fiscal year ended 31 March 2021, ONOPHARMACEUTICAL CO., LTD. revenues increased 6% to Y309.28B.Net income applicable to common stockholders increased 26%to Y75.43B. Revenues reflect Products & Goods segmentincrease of 4% to Y214.54B, Keytruda segment increase of26% to Y24.33B, Japan (Country) segment increase of 5% toY212.87B, Americas (Region) segment increase of 5% toY85.57B.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for 4528
Graphical History

Revenue

4528 Revenue Unlock 4528 Revenue

Net Income

4528 Net Income Unlock 4528 Revenue

Normalised EPS

4528 Normalised EPS Unlock 4528 Revenue

PE Ratio Range

4528 PE Ratio Range Unlock 4528 Revenue

Dividend Yield Range

4528 Dividend Yield Range Unlock 4528 Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
4528 EPS Forecasts Unlock 4528 Revenue
Profile Summary

ONO PHARMACEUTICAL CO., LTD. is a Japan-based company primarily engaged in the manufacture and sale of pharmaceuticals. The Company operates in one business segment. The Pharmaceutical segment involves in the manufacture and sale of drugs for medical and general use. The Company also involves in the clinical development, introduction and derivation of pharmaceuticals.

Directors
Last Annual March 31st, 2021
Last Interim March 31st, 2021
Incorporated July 4, 1947
Public Since January 1, 1962
No. of Shareholders: 67,153
No. of Employees: 3,607
Sector Healthcare
Industry Pharmaceuticals
Index
Exchange Tokyo Stock Exchange
Shares in Issue 499,141,984
Free Float (0.0%)
Eligible for
ISAs
SIPPs
4528 Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for 4528
Upcoming Events for 4528
Wednesday 29th September, 2021
Dividend For 4528.T - 28.0000 JPY
Wednesday 27th October, 2021 Estimate
Q2 2022 Ono Pharmaceutical Co Ltd Earnings Release
Frequently Asked Questions for Ono Pharmaceutical Co
What is the Ono Pharmaceutical Co share price?

As of 30/07/21, shares in Ono Pharmaceutical Co are trading at ¥2485.5, giving the company a market capitalisation of £8.12bn. This share price information is delayed by 15 minutes.

How has the Ono Pharmaceutical Co share price performed this year?

Shares in Ono Pharmaceutical Co are currently trading at ¥2485.5 and the price has moved by -16.91% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Ono Pharmaceutical Co price has moved by -31.97% over the past year.

What are the analyst and broker recommendations for Ono Pharmaceutical Co?

Of the analysts with advisory recommendations for Ono Pharmaceutical Co, there are there are currently 3 "buy" , 8 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Ono Pharmaceutical Co is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will Ono Pharmaceutical Co next release its financial results?

Ono Pharmaceutical Co is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2022-03-31
What is the Ono Pharmaceutical Co dividend yield?

The Ono Pharmaceutical Co dividend yield is 2.01% based on the trailing twelve month period.

Does Ono Pharmaceutical Co pay a dividend?

Last year, Ono Pharmaceutical Co paid a total dividend of 50, and it currently has a trailing dividend yield of 2.01%. Looking ahead, shares in Ono Pharmaceutical Co are due to go ex-dividend on 2021-09-29 and the next dividend pay date is 2021-12-01.

When does Ono Pharmaceutical Co next pay dividends?

Ono Pharmaceutical Co are due to go ex-dividend on 2021-09-29 and the next dividend pay date is 2021-12-01. The historic dividend yield on Ono Pharmaceutical Co shares is currently 2.01%.

How do I buy Ono Pharmaceutical Co shares?

To buy shares in Ono Pharmaceutical Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Ono Pharmaceutical Co?

Shares in Ono Pharmaceutical Co are currently trading at ¥2485.5, giving the company a market capitalisation of £8.12bn.

Where are Ono Pharmaceutical Co shares listed? Where are Ono Pharmaceutical Co shares listed?

Here are the trading details for Ono Pharmaceutical Co:

Country of listing: Japan
Exchange: TYO
Ticker Symbol: 4528
What kind of share is Ono Pharmaceutical Co?

Based on an overall assessment of its quality, value and momentum, Ono Pharmaceutical Co is currently classified as a Falling Star. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Ono Pharmaceutical Co share price forecast 2021?

Shares in Ono Pharmaceutical Co are currently priced at ¥2485.5. At that level they are trading at 32.62% discount to the analyst consensus target price of 0.00.

Analysts covering Ono Pharmaceutical Co currently have a consensus Earnings Per Share (EPS) forecast of 167.77 for the next financial year.

How can I tell whether the Ono Pharmaceutical Co share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Ono Pharmaceutical Co. Over the past six months, the relative strength of its shares against the market has been -18.11%. At the current price of ¥2485.5, shares in Ono Pharmaceutical Co are trading at -14.41% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Ono Pharmaceutical Co PE Ratio?

The Ono Pharmaceutical Co PE ratio based on its reported earnings over the past 12 months is 16.45. The shares are currently trading at ¥2485.5.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Ono Pharmaceutical Co?

Ono Pharmaceutical Co's management team is headed by:

Isao Ono - MEO
Shozo Matsuoka - MEO
Gyo Sagara - PRE
Hiroshi Ichikawa - MEO
Hiroshi Awata - EVP
Toichi Takino - MEO
Jun Kurihara - IND
Yukio Tani - MEO
Toshihiro Tsujinaka - MEO
Masao Nomura - IND
Kiyoaki Idemitsu - MEO
Keiji Masui - DSL
Akiko Okuno - IND
Who are the major shareholders of Ono Pharmaceutical Co?

Here are the top five shareholders of Ono Pharmaceutical Co based on the size of their shareholding:

Wellington Management Company, LLP Investment Advisor/Hedge Fund
Percentage owned: 5.94% (31.4m shares)
Mitsubishi UFJ Trust and Banking Corporation Bank and Trust
Percentage owned: 4.01% (21.2m shares)
Vanguard Health Care Fund Mutual Fund
Percentage owned: 3.72% (19.6m shares)
Meiji Yasuda Life Insurance Company Insurance Company
Percentage owned: 3.52% (18.6m shares)
Shogakukai (Ono) Individual Investor
Percentage owned: 3.11% (16.4m shares)
Similar to 4528
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.